Literature DB >> 2596869

Cutaneous reactions to kallikrein and histamine in patients with urticaria.

S Imai1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596869     DOI: 10.1007/bf00455332

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  9 in total

1.  Studies on experimental itch induced by kallikrein and bradykinin.

Authors:  O Hägermark
Journal:  Acta Derm Venereol       Date:  1974       Impact factor: 4.437

2.  Treatment of chronic urticaria with a proteinase (kallikrein) inhibitor.

Authors:  N Berova; I Petkov; V C Andreev
Journal:  Br J Dermatol       Date:  1974-04       Impact factor: 9.302

3.  Chronic urticaria. A clinical study with special reference to vascular reactions mediated by the kallikrein-kinin system.

Authors:  G Michaëlsson
Journal:  Acta Derm Venereol       Date:  1969       Impact factor: 4.437

4.  Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema.

Authors:  L Juhlin; G Michaëlsson
Journal:  Acta Derm Venereol       Date:  1969       Impact factor: 4.437

5.  Cutaneous reactions to kallikrein, bradykinin and histamine in healthy subjects and in patients with urticaria.

Authors:  L Juhlin; G Michaëlsson
Journal:  Acta Derm Venereol       Date:  1969       Impact factor: 4.437

6.  [Plasmakinins].

Authors:  E Werle
Journal:  Dtsch Med Wochenschr       Date:  1967-09-01       Impact factor: 0.628

7.  Induction of late cutaneous reaction by kallikrein injection: comparison with allergic-like late response to compound 48/80.

Authors:  P J Dor; D Vervloet; M Sapene; L Andrac; J J Bonerandi; J Charpin
Journal:  J Allergy Clin Immunol       Date:  1983-04       Impact factor: 10.793

8.  Protease inhibitors in plasma of patients with chronic urticaria.

Authors:  H M Doeglas; E Bleumink
Journal:  Arch Dermatol       Date:  1975-08

9.  Recurrent urticaria: clinical investigation of 330 patients.

Authors:  L Juhlin
Journal:  Br J Dermatol       Date:  1981-04       Impact factor: 9.302

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.